YOLT-201

· YolTech Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for YOLT-201, covering 2024-08-06 to 2025-02-14. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Intravenous YOLT-201 for Transthyretin Amyloidosis Cardiomyopathy [EARLY_Phase 1]